Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1994 1
1999 1
2000 1
2001 7
2002 3
2003 2
2004 3
2005 1
2006 1
2007 1
2008 3
2009 5
2010 5
2011 2
2012 4
2013 6
2014 2
2015 4
2016 6
2017 9
2018 8
2019 13
2020 8
2021 9
2022 12
2023 9
2024 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.
Mathur M, Barratt J, Chacko B, Chan TM, Kooienga L, Oh KH, Sahay M, Suzuki Y, Wong MG, Yarbrough J, Xia J, Pereira BJG; ENVISION Trial Investigators Group. Mathur M, et al. N Engl J Med. 2024 Jan 4;390(1):20-31. doi: 10.1056/NEJMoa2305635. Epub 2023 Nov 2. N Engl J Med. 2024. PMID: 37916620 Free PMC article. Clinical Trial.
Cirrhotic portal hypertension: From pathophysiology to novel therapeutics.
Gunarathne LS, Rajapaksha H, Shackel N, Angus PW, Herath CB. Gunarathne LS, et al. Among authors: herath cb. World J Gastroenterol. 2020 Oct 28;26(40):6111-6140. doi: 10.3748/wjg.v26.i40.6111. World J Gastroenterol. 2020. PMID: 33177789 Free PMC article. Review.
A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis.
Rovin BH, Solomons N, Pendergraft WF 3rd, Dooley MA, Tumlin J, Romero-Diaz J, Lysenko L, Navarra SV, Huizinga RB; AURA-LV Study Group. Rovin BH, et al. Kidney Int. 2019 Jan;95(1):219-231. doi: 10.1016/j.kint.2018.08.025. Epub 2018 Nov 9. Kidney Int. 2019. PMID: 30420324 Free article. Clinical Trial.
The authors reply.
Vervaet BA, Nast CC, Schreurs G, Jayasumana C, Herath C, De Broe ME. Vervaet BA, et al. Among authors: herath c. Kidney Int. 2020 Sep;98(3):787-789. doi: 10.1016/j.kint.2020.06.021. Epub 2020 Jul 2. Kidney Int. 2020. PMID: 32622832 Free article. No abstract available.
Signet ring cell mesothelioma; A diagnostic challenge.
Wang H, Herath C. Wang H, et al. Among authors: herath c. Pathol Res Pract. 2019 Jul;215(7):152462. doi: 10.1016/j.prp.2019.152462. Epub 2019 May 22. Pathol Res Pract. 2019. PMID: 31146976 Review.
Urinary cystatin C: pediatric reference intervals and comparative assessment as a biomarker of renal injury among children in the regions with high burden of CKDu in Sri Lanka.
Sandamini PMMA, De Silva PMCS, Gunasekara TDKSC, Gunarathna SD, Pinipa RAI, Herath C, Jayasinghe SS, Chandana EPS, Jayasundara N. Sandamini PMMA, et al. Among authors: herath c. World J Pediatr. 2022 Mar;18(3):196-205. doi: 10.1007/s12519-022-00513-9. Epub 2022 Feb 2. World J Pediatr. 2022. PMID: 35107783
121 results